作者
L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, RV Bryant, G d'Haens, I Dotan, M Dubinsky, B Feagan, G Fiorino, R Gearry, S Krishnareddy, PL Lakatos, EV Loftus Jr, P Marteau, P Munkholm, TB Murdoch, I Ordás, R Panaccione, RH Riddell, J Ruel, DT Rubin, M Samaan, CA Siegel, MS Silverberg, J Stoker, Stefan Schreiber, S Travis, G Van Assche, S Danese, J Panes, G Bouguen, S O'donnell, B Pariente, S Winer, S Hanauer, J-F Colombel
发表日期
2015/9/1
来源
Official journal of the American College of Gastroenterology| ACG
卷号
110
期号
9
页码范围
1324-1338
出版商
LWW
简介
OBJECTIVES:
The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a “treat-to-target” clinical management strategy using an evidence-based expert consensus process.
METHODS:
A Steering Committee of 28 IBD specialists developed recommendations based on a systematic literature review and expert opinion. Consensus was gained if≥ 75% of participants scored the recommendation as 7–10 on a 10-point rating scale (where 10= agree completely).
RESULTS:
学术搜索中的文章
L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch… - Official journal of the American College of …, 2015